International Journal of Drug Research and Technology

Arto Urtti

Department of Pharmaceutical Biosciences, University of Helsinki, 00014 University of Helsinki, Finland

Publications

• Opinion   
  Innovative Work of Chinese Enemy of Coronavirus Drugs
  Author(s): Arto Urtti*
  
  According to last update in several innovative Chinese antiviral drugs were under development or in use to combat the coronavirus disease (COVID-19) caused by the SARS-CoV-2 virus. These drugs aimed to treat COVID-19 patients, reduce disease severity, and prevent severe complications. Some notable Chinese antiviral drugs and treatments included. Originally developed by Gilead Sciences, is an antiviral drug that showed promising results in clinical trials against SARS-CoV-2. The government approved its emergency use in COVID-19 patients, and several Chinese pharmaceutical companies were involved in the production of the drug. Favipiravir is another antiviral drug developed by a Japanese company, but it gained attention in China for its potential against COVID-19. Some Chinese pharmaceutical companies produced generic versions of the drug, making it widely available for COVID-19 trea.. Read More»
  DOI: 10.37421/2277-1506.2023.12.410

  Abstract HTML PDF